Skip to main content

Table 2 Relationship between RC and DR or PDR in different models

From: The non-linear link between remnant cholesterol and diabetic retinopathy: a cross-sectional study in patients with type 2 diabetic mellitus

Variable

Crude model (OR,95%CI, P)

Model I (OR,95%CI, P)

Model II (OR,95%CI, P)

Model III (OR,95%CI, P)

DR

 RC (mg/dL)

1.001 (0.995, 1.008) 0.69304

1.000 (0.993, 1.006) 0.88369

1.001 (0.991, 1.011) 0.85549

0.999 (0.989, 1.010) 0.89030

RC (Quartile)

 Q1

Ref.

Ref.

Ref.

Ref.

 Q2

1.422 (1.087, 1.860) 0.01012

1.405 (1.067, 1.850) 0.01547

1.397 (1.055, 1.850) 0.01949

1.314 (0.980, 1.762) 0.06836

 Q3

1.318 (1.001, 1.735) 0.04921

1.263 (0.951, 1.676) 0.10622

1.282 (0.952, 1.727) 0.10155

1.184 (0.855, 1.639) 0.30996

 Q4

1.216 (0.925, 1.598) 0.16182

1.144 (0.860, 1.520) 0.35563

1.146 (0.801, 1.640) 0.45498

1.112 (0.757, 1.632) 0.58809

PDR

 RC (mg/dL)

1.003 (0.996, 1.011) 0.38149

1.002 (0.993, 1.010) 0.71030

1.009 (0.997, 1.022) 0.14995

1.008 (0.995, 1.021) 0.20586

RC (Quartile)

 Q1

Ref.

Ref.

Ref.

Ref.

 Q2

1.213 (0.858, 1.714) 0.27367

1.182 (0.828, 1.686) 0.35665

1.219 (0.849, 1.751) 0.28371

1.226 (0.851, 1.767) 0.27444

 Q3

1.435 (1.016, 2.025) 0.04023

1.388 (0.972, 1.982) 0.07125

1.559 (1.071, 2.271) 0.02056

1.552 (1.060, 2.273) 0.02384

 Q4

1.424 (1.012, 2.004) 0.04270

1.341 (0.938, 1.917) 0.10751

1.709 (1.096, 2.666) 0.01812

1.649 (1.048, 2.593) 0.03047

  1. Crude model: we did not adjust other covariants
  2. Model I: we adjusted age, sex, BMI, SBP, DBP, coronary artery disease, cerebrovascular disease, β-blocker use, ACEI and/or ARB use, diuretic use, calcium channel blocker use
  3. Model II: we adjusted age, sex, BMI, SBP, DBP, coronary artery disease, cerebrovascular disease, β-blocker use, ACEI and/or ARB use, diuretic use, calcium channel blocker use, FPG, HbA1c, eGFR, TG, microalbuminuria
  4. Model III: we adjusted age (smooth), sex, BMI (smooth), SBP (smooth), DBP (smooth), coronary artery disease, cerebrovascular disease, β-blocker use, ACEI and/or ARB use, diuretic use, calcium channel blocker use, FPG (smooth), HbA1c (smooth), eGFR (smooth), TG (smooth), microalbuminuria
  5. OR odds ratios, CI confidence, Ref reference